Location: Boston, MA
CIK: 0001703031 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $850M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 10,719,110 | $275M | 32.4% | $10.88 | +95.2% | ORDINARY SHARES | N62509109 |
| NUVL | NUVALENT INC | 1,447,267 | $113M | 13.3% | $28.96 | +222.4% | COM | 670703107 |
| PHVS | PHARVARIS N V | 3,303,381 | $63.33M | 7.4% | $23.89 | -13.8% | COM | N69605108 |
| IRON | DISC MEDICINE INC | 983,500 | $62.35M | 7.3% | $25.40 | +127.7% | COM | 254604101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,689,707 | $58.64M | 6.9% | $21.73 | +18.3% | COM | 252828108 |
| SVRA | SAVARA INC | 14,565,457 | $44.72M | 5.3% | $1.94 | +80.1% | COM | 805111101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,470,214 | $43.55M | 5.1% | $9.99 | 0.0% | COM | 68062P106 |
| UPB | UPSTREAM BIO INC | 2,295,322 | $37.74M | 4.4% | $22.33 | 0.0% | COM | 91678A107 |
| ANNX | ANNEXON INC | 5,249,069 | $26.93M | 3.2% | $11.24 | -45.2% | COM | 03589W102 |
| — | CIDARA THERAPEUTICS INC | 703,080 | $18.9M | 2.2% | $10.75 | — | COM NEW | 171757206 |
| SLDB | SOLID BIOSCIENCES INC | 4,034,582 | $16.14M | 1.9% | $7.18 | -23.5% | COM NEW | 83422E204 |
| KYTX | KYVERNA THERAPEUTICS INC | 3,368,370 | $12.6M | 1.5% | $27.08 | -82.3% | COM | 501976104 |
| — | X4 PHARMACEUTICALS INC | 16,915,784 | $12.41M | 1.5% | $2.56 | — | COM | 98420X103 |
| — | MERSANA THERAPEUTICS INC | 8,663,673 | $12.39M | 1.5% | $12.65 | — | COM | 59045L106 |
| TNGX | TANGO THERAPEUTICS INC | 2,712,008 | $8.38M | 1.0% | $10.01 | -53.6% | COM | 87583X109 |
| AVIR | ATEA PHARMACEUTICALS INC | 2,485,638 | $8.327M | 1.0% | $32.23 | -89.7% | COM | 04683R106 |
| RPID | RAPID MICRO BIOSYSTEMS INC | 8,434,560 | $7.591M | 0.9% | $20.66 | -95.1% | CLASS A COM | 75340L104 |
| CABA | CABALETTA BIO INC | 2,760,888 | $6.267M | 0.7% | $8.83 | -60.3% | COM | 12674W109 |
| IPSC | CENTURY THERAPEUTICS INC | 5,410,361 | $5.464M | 0.6% | $3.16 | -56.9% | COM | 15673T100 |
| XLO | XILIO THERAPEUTICS INC | 4,566,817 | $4.361M | 0.5% | $10.85 | -90.9% | COM | 98422T100 |
| CCCC | C4 THERAPEUTICS INC | 1,111,910 | $4.003M | 0.5% | $29.00 | -82.9% | COM STK | 12529R107 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 1,759,000 | $2.955M | 0.3% | $10.83 | -77.9% | COM | 63909J108 |
| — | MARINUS PHARMACEUTICALS INC | 2,693,380 | $1.441M | 0.2% | $8.67 | — | COM NEW | 56854Q200 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 100,000 | $1.425M | 0.2% | $0.86 | — | *W EXP 99/99/999 | N62509117 |
| IVVD | INVIVYD INC | 1,799,595 | $797K | 0.1% | $37.11 | -97.9% | COM | 00534A102 |
| SYRS | SYROS PHARMACEUTICALS INC | 2,750,151 | $632K | 0.1% | $5.62 | -78.6% | COM NEW | 87184Q206 |